Dare Bioscience acquires Cerulean in reverse merger
Executive Summary
Public biotech Cerulean Pharma Inc. (nanoparticle drug delivery) is reverse-merging with private women's health start-up Dare Bioscience Inc. to create a female reproductive health-focused company.
Deal Industry
- Biotechnology
- Pharmaceuticals
-
Pharmaceuticals
- Drug Delivery
Deal Status
- Final
Deal Type
-
Acquisition
- Includes Contract
- Payment Includes Stock
- Reverse Acquisition
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice